Not yet recruiting
Hormone-refractory prostate cancer
Not yet recruitingStudy of Benfooxythiamine Monosodium Added to Lutetium‑177 Vipivotide Tetraxetan in Adults with Metastatic Castration‑Resistant Prostate Cancer and Stable Disease
InvestigationalNo placebo
Study of Benfooxythiamine Monosodium Added to Lutetium‑177 Vipivotide Tetraxetan in Adults with Metastatic Castration‑Resistant Prostate Cancer and Stable Disease
InvestigationalNo placebo
- Disease:Hormone-refractory prostate cancer
- Substances:–
Countries:
Germany
Germany- Participants:18–64 years · 65+ years
- Sponsor:Benfovir AG
